As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production,

(MedPage Today) — Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a

Diabetes Mellitus (DM) is a rapidly increasing disease around the world. It is known that DM is associated with numerous complications which affect life quality

A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong

This content was created by Hive Labs in partnership with Fairfax Partners on behalf of LIR Life Sciences Corp. Treating obesity isn’t always as simple

According to doctors, making a misstep is easier than you may think.

Developed by board-certified endocrinologist Dr. Eiriny Eskander, Caloria delivers physician-backed insights for people managing GLP-1 use, diabetes, PCOS, and menopause. LOS ANGELES, Jan. 26, 2026

Post Content

Danish national registry data suggest adults with type 2 diabetes taking SGLT2 inhibitors have a slightly lower risk of developing diabetic foot problems than those

Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and

Abstract Background Parkinson’s disease (PD) is an increasingly prevalent neurodegenerative condition, particularly among individuals with type 2 diabetes mellitus (T2DM). While prior studies have suggested

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, Inc. (NASDAQ:VKTX) announced a significant

As GLP-1 drugs become more available, some people might use them despite not having excess weight.

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that aims to trigger long-term weight loss by programming the pancreas to produce

World-leading gut health expert PROFESSOR TIM SPECTOR reveals brand new research around why dementia, depression, and anxiety may start in the gut, how flossing lowers

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk

(MedPage Today) — LAS VEGAS — GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their metabolic indication, according to two

Engineering of marker-free lettuce chloroplast genome to express CTB-Exenatide and CTB-Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification,

Five ways weight-loss jabs are changing spending habits  BBC Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus  NBC News Gut-friendly foods: GLP-1 drives

The Seven Deadly Sins of Weight Loss Drugs by Alan Cassels at Brownstone Institute O is for Obesity…. Back in the days, we saw a

Key Points Some Medicare costs are going up — which is no suprise. Some costs, though, including some prescription drug costs, are going down. Original

Fractyl Health is developing a shot that would program the body to make more of the GLP-1 hormone naturally, a risky bet that it can

Victoza, ​approved by the US ⁠Food and Drug Administration in 2010, was Novo’s first-generation blockbuster GLP-1 drug

Novo Nordisk’s weight loss pill is off to an impressive start after less than three weeks on the market. Prescriptions are quickly ramping up, increasing

Fairfax, Va.-based George Mason University is leading a phase 2 clinical trial of ARD-201, an oral medication designed to help patients maintain weight loss after

“I never, ever thought that this would happen.”

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of

Who would have ever thought that a weight loss injectable would become a household name and pop culture-adjacent phenomenon? Ozempic has become synonymous with modern

Richard M Lee/Shutterstock Consumers are surrounded by food that is highly conducive to weight gain. No one likes dieting and very few have lasting success.

Many patients may keep off lost pounds after stopping a GLP-1, US data suggests  Reuters

GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits more than motivation alone.

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two

Since its 2019 founding, Corxel Pharmaceuticals has evolved from focusing on the China market to eyeing the world. The biopharma, founded in Shanghai but now

In 2024, the US Centers for Disease Control and Prevention published “what could well be the most important table in modern public health”, said Tom

WICHITA FALLS, Texas, Jan. 22, 2026 /PRNewswire/ — CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed to

The US group has re-hired former CEO Joe Scalzo as sales falter and as GLP-1 trend presents opening for Atkins brand.